Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1
G protein-coupled estrogen receptor 1 (GPER1) is a potential therapeutic target for treating triple-negative breast cancers (TNBC). However, modulators for GPER1 that can be used to treat TNBC have not appeared. Berberine (BBR) is a bioactive isoquinoline alkaloid with high oral safety. In recent ye...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07058c31455d4bdaa6655fe7ee9f56ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:07058c31455d4bdaa6655fe7ee9f56ec |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:07058c31455d4bdaa6655fe7ee9f56ec2021-11-11T16:55:44ZBerberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 110.3390/ijms2221114661422-00671661-6596https://doaj.org/article/07058c31455d4bdaa6655fe7ee9f56ec2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11466https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067G protein-coupled estrogen receptor 1 (GPER1) is a potential therapeutic target for treating triple-negative breast cancers (TNBC). However, modulators for GPER1 that can be used to treat TNBC have not appeared. Berberine (BBR) is a bioactive isoquinoline alkaloid with high oral safety. In recent years, BBR has shown an inhibitory effect on TNBC tumors such as MDA-MB-231, but the molecular target remains unclear, which hinders related clinical research. Our work proved that BBR is a modulator of GPER1 that can inhibit cell viability, migration, and autophagy of MDA-MB-231 cells. The inhibitory effect of BBR on MDA-MB-231 cells has a dependence on estrogen levels. Although BBR promoted the proteasome, which is a major factor in the degradation of GPER1, it could still induce the protein level of GPER1. Correspondingly, the transcription of cellular communication network factor 2 (CCN2) was promoted. BBR could bind to GPER1 directly and change the secondary structure of GPER1, as in the case of 17β-estradiol (E2). In addition, BBR induced not only a high degree of co-localization of GPER1 and microtubule-associated protein 1 light chain 3 (MAP1LC3), but also the accumulation of sequestosome 1 (SQSTM1/p62) by the inhibition of the nuclear translocation of the nuclear factor-kappa B (NF-κB) subunit (RELA/p65), which indicates NF-κB inhibition and anti-cancer effects. This result proved that the promotional effect of BBR on the GPER1/NF-κB pathway was closely related to its inhibitory effect on autophagy, which may serve as a new mechanism by which to explain the inhibitory effect of BBR on MDA-MB-231 cells and expand our understanding of the function of both BBR and GPER1.Miaomiao QiXiang LiuYing ZhouHaoyu WangYing ZhaoJing RenJin XiangMDPI AGarticleberberinebindingco-localizationGPER1MAP1LC3NF-κBBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11466, p 11466 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
berberine binding co-localization GPER1 MAP1LC3 NF-κB Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
berberine binding co-localization GPER1 MAP1LC3 NF-κB Biology (General) QH301-705.5 Chemistry QD1-999 Miaomiao Qi Xiang Liu Ying Zhou Haoyu Wang Ying Zhao Jing Ren Jin Xiang Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1 |
description |
G protein-coupled estrogen receptor 1 (GPER1) is a potential therapeutic target for treating triple-negative breast cancers (TNBC). However, modulators for GPER1 that can be used to treat TNBC have not appeared. Berberine (BBR) is a bioactive isoquinoline alkaloid with high oral safety. In recent years, BBR has shown an inhibitory effect on TNBC tumors such as MDA-MB-231, but the molecular target remains unclear, which hinders related clinical research. Our work proved that BBR is a modulator of GPER1 that can inhibit cell viability, migration, and autophagy of MDA-MB-231 cells. The inhibitory effect of BBR on MDA-MB-231 cells has a dependence on estrogen levels. Although BBR promoted the proteasome, which is a major factor in the degradation of GPER1, it could still induce the protein level of GPER1. Correspondingly, the transcription of cellular communication network factor 2 (CCN2) was promoted. BBR could bind to GPER1 directly and change the secondary structure of GPER1, as in the case of 17β-estradiol (E2). In addition, BBR induced not only a high degree of co-localization of GPER1 and microtubule-associated protein 1 light chain 3 (MAP1LC3), but also the accumulation of sequestosome 1 (SQSTM1/p62) by the inhibition of the nuclear translocation of the nuclear factor-kappa B (NF-κB) subunit (RELA/p65), which indicates NF-κB inhibition and anti-cancer effects. This result proved that the promotional effect of BBR on the GPER1/NF-κB pathway was closely related to its inhibitory effect on autophagy, which may serve as a new mechanism by which to explain the inhibitory effect of BBR on MDA-MB-231 cells and expand our understanding of the function of both BBR and GPER1. |
format |
article |
author |
Miaomiao Qi Xiang Liu Ying Zhou Haoyu Wang Ying Zhao Jing Ren Jin Xiang |
author_facet |
Miaomiao Qi Xiang Liu Ying Zhou Haoyu Wang Ying Zhao Jing Ren Jin Xiang |
author_sort |
Miaomiao Qi |
title |
Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1 |
title_short |
Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1 |
title_full |
Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1 |
title_fullStr |
Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1 |
title_full_unstemmed |
Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1 |
title_sort |
berberine inhibits mda-mb-231 cells as an agonist of g protein-coupled estrogen receptor 1 |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/07058c31455d4bdaa6655fe7ee9f56ec |
work_keys_str_mv |
AT miaomiaoqi berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1 AT xiangliu berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1 AT yingzhou berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1 AT haoyuwang berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1 AT yingzhao berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1 AT jingren berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1 AT jinxiang berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1 |
_version_ |
1718432159840075776 |